VeriMommorus bombycis root extract hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction was identified for Morus bombycis (mulberry) root extract, and there are no consistent peer‑reviewed reports showing developmental or reproductive toxicity from topical use; regulatory databases (CosIng, PubChem) list this as a botanical extract without reproductive hazard labels. Therefore default no evidence of reproductive hazard (h=0), no established reproductive mechanism (m=0), and negligible dermal exposure expected for typical cosmetic use (e=0). Sources: ECHA Annex VI (no harmonised classification), CosIng, PubChem, PubMed.
Pregnancy-safe products containing morus bombycis root extract
Related ingredients
Frequently asked questions
- morus bombycis root extract hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction was identified for Morus bombycis (mulberry) root extract, and there are no consistent peer‑reviewed reports showing developmental or reproductive toxicity from topical use; regulatory databases (CosIng, PubChem) list this as a botanical extract without reproductive hazard labels. Therefore default no evidence of reproductive hazard (h=0), no established reproductive mechanism (m=0), and negligible dermal exposure expected for typical cosmetic use (e=0). Sources: ECHA Annex VI (no harmonised classification), CosIng, PubChem, PubMed.
- morus bombycis root extract emzirirken güvenli mi?
- There are no authoritative assessments (CIR/SCCS/ECHA harmonised) indicating lactation/breastmilk transfer or adverse effects to nursing infants from Morus bombycis root extract, nor peer‑reviewed human data demonstrating transfer via milk; therefore default no evidence of hazard or mechanism (h=0, m=0) and exposure from topical cosmetic use is considered negligible (e=0). Sources: CosIng, PubMed, CIR (no specific assessment found).
- morus bombycis root extract bebek cildi için güvenli mi?
- No specific infant toxicity or developmental effects were identified (h=0, m=0). Because infant skin has higher permeability and there are no infant‑specific dermal absorption data for this botanical, exposure is increased one category versus adults (e=1) to reflect greater potential percutaneous uptake in 0–3 yr olds for ingredients that are not known to be completely non‑absorbable. Sources: general toxicology principles, CosIng, PubMed.
- VeriMom morus bombycis root extract nasıl puanlıyor?
- VeriMom morus bombycis root extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte morus bombycis root extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.